Search for: "In Re: Mylan Technologies Inc."
Results 1 - 20
of 76
Sorted by Relevance
|
Sort by Date
18 Apr 2017, 6:52 am
" In re Swinehart, 439 F.2d 210, 213, 58 C.C.P.A. 1027 (C.C.P.A. 1971). [read post]
18 Dec 2009, 9:59 am
Mylan Pharmaceuticals Inc., Mylan, Inc., Matrix Laboratories Ltd. and Matrix Laboratories Inc. [read post]
4 Dec 2013, 4:03 am
FAS Technologies, Inc., 138 F.3d 1448 (Fed. [read post]
7 Sep 2006, 3:46 pm
Mylan Laboratories, Inc., et al. [read post]
22 Jul 2010, 11:59 am
Mylan Labs., Inc., 464 F.3d 1286, 1289 (Fed. [read post]
14 Dec 2021, 9:57 am
VLSI Technology LLC (Follow-on case to Mylan v. [read post]
28 Jun 2016, 6:41 am
NuVasive, Inc., No. 15-85 (Commil re-hash – mens rea requirement for inducement) 3. [read post]
20 Jan 2016, 8:00 am
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
25 Oct 2008, 12:03 am
Sandoz, Inc (Law360) (Hal Wegner) (Patently-O) (Patent Prospector) (PLI) Cipro (Ciprofloxacin) - US: CAFC finds no antitrust liability for Hatch-Waxman reverse payment settlements: In Re Ciproflaxacin Hydrochloride Antitrust Litigation (IP Law Observer) Lescol (Fluvastatin) - US: Mylan confirms first-to-file patent challenge to Lescol by Novartis (SmartBrief) Levaquin (Levofloxacin) - UK: Levofloxacin SPC valid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd… [read post]
12 Jan 2016, 11:39 am
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
1 Jan 2016, 9:00 am
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
15 Jun 2011, 4:56 am
Mylan Inc. et al. [read post]
4 Mar 2016, 12:25 pm
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
17 Feb 2016, 9:20 am
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
3 Feb 2016, 8:57 am
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
2 Sep 2009, 11:22 pm
Mylan Laboratories, Inc., 2008 WL 4813311, at *6-7 (D. [read post]
1 Apr 2016, 8:22 am
NuVasive, Inc., No. 15-85 (Commil re-hash – mens rea requirement for inducement) 3. [read post]
17 Mar 2016, 2:45 am
NuVasive, Inc., No. 15-85 (Commil re-hash – mens rea requirement for inducement) 3. [read post]
24 Sep 2010, 1:15 pm
Mylan Labs, Inc., 520 F.3d 1358 (Fed. [read post]
3 Jun 2016, 6:40 am
NuVasive, Inc., No. 15-85 (Commil re-hash – mens rea requirement for inducement) 3. [read post]